Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Sol-Gel Technologies

NASDAQ SLGL
$0.85 0.0000 0.0000%
Today share price
Israel
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 15 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

23.69M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
16.62M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.30
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
27.86M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-23.04 %

Upcoming events Sol-Gel Technologies

All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Sol-Gel Technologies

Stock analysis Sol-Gel Technologies

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.50 35.47
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.61 14.09
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
- 17.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
- 0.37
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-123.30 8.90

Price change Sol-Gel Technologies per year

7.25$ 16.69$
Min Max

Summary analysis Sol-Gel Technologies

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Sol-Gel Technologies

Revenue and net income Sol-Gel Technologies

All parameters

Stock news Sol-Gel Technologies

All news
25 April 2022 в 14:36

Sol-Gel Technologies Shares Up After FDA Approves Epsolay

25 April 2022 в 14:36

Sol-Gel Technologies Shares Up After FDA Approves Epsolay

About company Sol-Gel Technologies

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. Sol-Gel Technologies Ltd. has collaboration with Perrigo. The company was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Address:
7 Golda Meir Street, Ness Ziona, Israel, 7403650
Company name: Sol-Gel Technologies
Issuer ticker: SLGL
ISIN: IL0011417206
Country: Israel
Exchange: NASDAQ
Currency: $
IPO date: 2018-01-23
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.sol-gel.com

On which stock exchange are Sol-Gel Technologies (SLGL) stocks traded?

Sol-Gel Technologies (SLGL) stocks are traded on NASDAQ.

What is the ticker of Sol-Gel Technologies stocks (SLGL)?

The stock ticker of Sol-Gel Technologies’s stocks or in other words, the code is SLGL. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Sol-Gel Technologies (SLGL) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Sol-Gel Technologies (SLGL) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Sol-Gel Technologies (SLGL) stocks traded?

Sol-Gel Technologies (SLGL) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Sol-Gel Technologies (SLGL) stocks today?

The current price of Sol-Gel Technologies stocks on 05.05.2024 is 0.8504 dollars. per share.

What is the dynamics of Sol-Gel Technologies (SLGL) stocks from the beginning of the year?

Sol-Gel Technologies (SLGL) quotes have increased by -30.3% from the beginning of the year up to 0.8504 dollars. per 1 stocks.

How much did Sol-Gel Technologies (SLGL) stocks increase in мае 2024?

This month Sol-Gel Technologies (SLGL) quotes have increased by 8.75% to 0.8504 dollars. per share.

How much are Sol-Gel Technologies (SLGL) stocks worth?

Today, on October, 05.05.2024 Sol-Gel Technologies’s (SLGL) stocks cost 0.8504 dollars..

What is the market capitalization of Sol-Gel Technologies (SLGL)?

Capitalization is the market value of Sol-Gel Technologies (SLGL) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 05.05.2024, the market capitalization of Sol-Gel Technologies (SLGL) is estimated at about 23690120 dollars.